Session information

Symposium

[SY07] Symposium 7　How should we face multiple challenge with novel and diverse early phase oncology drug development in Asia? Developmental Therapeutics -New Targets and New Technologies-
【E】

Thu. Feb 17, 2022 3:50 PM - 5:20 PM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Toshio Shimizu（Department of Experimental Therapeutics, National Cancer Center Hospital），Daniel SW Tan（Division of Medical Oncology, National Cancer Centre Singapore）

+Add all to schedule

[SY07-1] New guidelines for clinical evaluation of anti-cancer drugs in Japan

^○Hironobu Minami (Medical Oncology/Hematology, Kobe University Graduate School of Medicine)

[SY07-2] Where are we going to challenge to work for novel and diverse early phase oncology drug development ?

^○Toshihiko Doi (Department of Experimental Therapeutics, National Cancer Center Hospital East)

[SY07-3] Diversity and disparities in Asia: opportunities for drug development

^○Daniel SW Tan (Division of Medical Oncology, National Cancer Centre Singapore)

[SY07-4] History and future of oncology early phase global clinical development in Asia

^○Janna Sand Dejmek (Translational Clinical Oncology, NIBR Shanghai)

▲